Research indicates that B cells contribute substantially to the inflammatory environment of the CNS in MS patients by releasing pro-inflammatory factors, like IL-6 and TNF-α, and reducing anti-inflammatory factors, like IL-10, thereby sustaining a state of chronic inflammation (Delgado et al., 2024). The gene discussed is IL10; the disease is myeloid sarcoma.